Ultrasonographic and endocrine evaluation of ovarian function among norplant® implants users with regular menses

Contraception

Volumn 54, Issue 5, 1996, Pages 275-279

  Alvarez Sánchez, Francisco ^a   Brache, Vivian ^a   Faundes, Anibal ^b   Tejada, Ana Sofia ^a   Thevenin, Francisco ^a  

^a PROFAMILIA   (Dominican Republic)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

anovulation; luteinized unruptured follicle; Norplant implants; persistent follicle

Indexed keywords

ESTRADIOL; FOLLITROPIN; LEVONORGESTREL; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HORMONAL CONTRACEPTION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANT; LUTEINIZATION; MENSTRUAL CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION;

EID: 0030298541     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00179-5     Document Type: Article

References (14)

1. 1. Sivin I. International experience with Norplant implants and Norplant implants-2 contraceptives. Stud Fam Plann 1988;19:81.
2. 2. Grubb GS, Moore D, Anderson NG. Pre-introductory clinical trials of Norplant implants: A comparison of seventeen countries experience. Contraception 1995; 52:287-96.
3. 3. Croxatto HB, Diaz S, Pavez M, Miranda P, Brandeis A. Plasma progesterone levels during long-term treatment with levonorgestrel Silastic implants. Acta Endocrinol (Copenh) 1992;101:307.
4. 4. Brache V, Faúndes A, Johansson E, Alvarez F. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. Contraception 1985;31:261.
5. 5. Brache V, Alvarez F, Faúndes A, Tejada AS, Cochón L. Ovarian endocrine function through five years continuous treatment with Norplant subdermal implants. Contraception 1990;41:160-77.
6. 6. Croxatto HB, Diaz S, Salvatierra AM, Morales P, Ebensperger C, Brandeis A. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 1987;36:193.
7. 7. Alvarez F, Brache V, Tejada AS, Faúndes A. Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant implants use. Contraception 1986;33:111-9.
8. 8. Faúndes A, Brache V, Tejada AS, Cochón L, Alvarez F. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. Fertil Steril 1991;56:27-31.
9. 9. Olsson SE, Bakos O, Lindgren PG, Odlind V, Wide L. Ovarian function during use of subdermal implants releasing low doses of levonorgestrel. Brit J Fam Plann 1990;16:88-93.
10. 10. Shoupe D, Horenstein J, Mishell Jr DR, Lacarra M, Medearis A. Characteristics of ovarian follicular development in Norplant implants users. Fertil Steril 1991; 55:766-70.
11. 11. Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa E-AM, Ahmed A-G. Sonographic assessment of ovarian and endometrial changes during long-term Norplant implants use and their correlation with hormonal levels. Fertil Steril 1993;59:998-1002.
12. 12. Hamilton CJCM, Wetzels LCG, Evers JLH, Hoogland HJ, Muijtjens A, de Haan J. Follicle growth curves and hormonal patterns in patients with the luteinized unruptured follicle syndrome. Fertil Steril 1985;43:541-8.
13. 13. Hamilton CJCM, Evers JLH, de Haan J. Ovulatory disturbances in patients with luteal insufficiency. Clin Endocrinol (Oxford) 1987;26:129-36.
14. 14. Hamilton MPR, Fleming R, Coutts JRT, Macnaughton MC, Whitfield CR. Luteal cysts and unexplained infertility: Biochemical and ultrasonic evaluation. Fertil Steril 1990;54:32-7.